Ablation Technology Market by Technology (Radiofrequency, Ultrasound, Microwave, Laser, Cryoablation, Pulse-field), Product (Systems, Consumables), Application (Cardiovascular, Cancer, Urological), End User (Hospitals, ASC) - Global Forecasts to 2031

1 INTRODUCTION 33 1.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 STUDY SCOPE 34 1.3.1 MARKET SEGMENTATION AND REGIONS CONSIDERED 34 1.3.2 INCLUSIONS & EXCLUSIONS 35 1.3.3 YEARS CONSIDERED 35 1.3.4 CURRENCY CONSIDERED 36 1.3.5 UNITS CONSIDERED 36 1.4 STAKEHOLDERS 36 1.5 SUMMARY OF CHANGES 36 2 EXECUTIVE SUMMARY 38 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 38 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 41 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 42 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 43 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 44 3 PREMIUM INSIGHTS 45 3.1 ABLATION TECHNOLOGY MARKET OVERVIEW 45 3.2 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2025) 46 3.3 ABLATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES (2025) 47 3.4 ABLATION TECHNOLOGY MARKET, BY REGION (2024−2031) 48 3.5 ABLATION TECHNOLOGY MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 48 4 MARKET OVERVIEW 49 4.1 INTRODUCTION 49 4.1.1 DRIVERS 50 4.1.1.1 Emerging ablation technologies 50 4.1.1.2 Increasing demand for minimally invasive procedures 50 4.1.1.3 Increasing geriatric population worldwide 51 4.1.1.4 Rising prevalence of chronic diseases 51 4.1.2 RESTRAINTS 53 4.1.2.1 Strong market positioning of alternative therapies 53 4.1.2.2 Stringent regulatory systems 54 4.1.2.3 High cost of advanced ablation devices and procedures 54 4.1.3 OPPORTUNITIES 55 4.1.3.1 Growth potential in emerging economies 55 4.1.3.2 Growing demand for pulsed field ablation (PFA) and non-thermal ablation technologies 56 4.1.4 CHALLENGES 57 4.1.4.1 Concerns regarding long-term efficacy and recurrence rates in certain ablation procedures 57 4.1.4.2 Therapeutic challenges and hazardous effects of ablation 57 4.2 UNMET NEEDS AND WHITE SPACES 58 4.2.1 UNMET NEEDS IN ABLATION TECHNOLOGY MARKET 58 4.2.2 WHITE SPACE OPPORTUNITIES 59 4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60 4.3.1 INTERCONNECTED MARKET 60 4.3.2 CROSS-SECTOR OPPORTUNITIES 61 4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63 5 INDUSTRY TRENDS 64 5.1 PORTER’S FIVE FORCES ANALYSIS 64 5.1.1 THREAT OF NEW ENTRANTS 65 5.1.2 THREAT OF SUBSTITUTES 65 5.1.3 BARGAINING POWER OF SUPPLIERS 65 5.1.4 BARGAINING POWER OF BUYERS 65 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 65 5.2 MACROECONOMIC OUTLOOK 66 5.2.1 INTRODUCTION 66 5.2.2 GDP TRENDS AND FORECAST 66 5.2.3 TRENDS IN GLOBAL ELECTROPHYSIOLOGY INDUSTRY 68 5.2.4 TRENDS IN GLOBAL PAIN MANAGEMENT DEVICES INDUSTRY 68 5.3 SUPPLY CHAIN ANALYSIS 68 5.4 VALUE CHAIN ANALYSIS 69 5.4.1 RESEARCH & PRODUCT DEVELOPMENT 70 5.4.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 70 5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 71 5.5 ECOSYSTEM ANALYSIS 71 5.6 PRICING ANALYSIS (2023–2025) 72 5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2025) 72 5.6.2 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025) 72 5.7 TRADE ANALYSIS 73 5.7.1 IMPORT SCENARIO FOR HS CODE 9018 73 5.7.2 EXPORT SCENARIO FOR HS CODE 9018 74 5.8 KEY CONFERENCES AND EVENTS, 2026–2027 74 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 75 5.10 INVESTMENT & FUNDING SCENARIO 76 5.11 CASE STUDY ANALYSIS 76 5.11.1 CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY 76 5.11.2 CASE STUDY 2: THERMOCOOL CATHETER CASE STUDY 77 5.11.3 CASE STUDY 3: HYBRID ABLATION LEFT VENTRICULAR FUNCTION NORMALIZED, MEDICATION REDUCED 77 5.12 IMPACT OF US TARIFFS—ABLATION TECHNOLOGY MARKET 78 5.12.1 INTRODUCTION 78 5.12.2 KEY TARIFF RATES 79 5.12.3 PRICE IMPACT ANALYSIS 80 5.12.4 IMPACT ON COUNTRIES/REGIONS 80 5.12.4.1 US 80 5.12.4.2 Europe 81 5.12.4.3 Asia Pacific 81 5.12.5 IMPACT ON END-USER INDUSTRIES 81 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83 6.1 KEY EMERGING TECHNOLOGIES 83 6.1.1 THERMAL ABLATION TECHNOLOGY 83 6.1.2 NON-THERMAL ABLATION TECHNOLOGY 83 6.2 COMPLEMENTARY TECHNOLOGIES 84 6.2.1 MEDICAL COOLING SYSTEMS 84 6.3 ADJACENT TECHNOLOGIES 84 6.3.1 ABLATION PLANNING SOFTWARE 84 6.4 TECHNOLOGY/PRODUCT ROADMAP 84 6.4.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 85 6.4.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 86 6.4.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 87 6.5 PATENT ANALYSIS 88 6.6 FUTURE APPLICATIONS OF ABLATION TECHNOLOGY 89 6.7 IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKET 90 6.7.1 TOP USE CASES AND MARKET POTENTIAL 91 6.7.2 BEST PRACTICES IN ABLATION TECHNOLOGY PROCESSING 92 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ABLATION TECHNOLOGY 93 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94 6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ABLATION TECHNOLOGY MARKET 95 7 REGULATORY LANDSCAPE 97 7.1 REGIONAL REGULATIONS AND COMPLIANCE 97 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 7.1.2 REGULATORY FRAMEWORK 97 7.1.2.1 North America 97 7.1.2.1.1 US 97 7.1.2.1.2 Canada 99 7.1.2.2 Europe 101 7.1.2.3 Asia Pacific 103 7.1.2.3.1 Japan 103 7.1.2.3.2 China 104 7.1.2.3.3 India 106 7.1.2.4 Latin America 106 7.1.2.4.1 Brazil 106 7.1.3 INDUSTRY STANDARDS 106 7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 107 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 109 8.1 DECISION-MAKING PROCESS 109 8.2 KEY STAKEHOLDERS AND EVALUATION CRITERIA 109 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 109 8.2.2 BUYING CRITERIA 110 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 111 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 112 8.5 MARKET PROFITABILITY 112 8.5.1 REVENUE POTENTIAL 112 8.5.2 COST DYNAMICS 113 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 113 9 ABLATION TECHNOLOGY MARKET, BY TYPE 114 9.1 INTRODUCTION 115 9.2 RADIOFREQUENCY ABLATION 115 9.2.1 LOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH 115 9.3 LASER/LIGHT ABLATION 117 9.3.1 LOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME MONITORING TO AID MARKET GROWTH 117 9.4 ULTRASOUND ABLATION 118 9.4.1 HIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH 118 9.5 CRYOABLATION 119 9.5.1 FEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET 119 9.6 MICROWAVE ABLATION 120 9.6.1 FASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH 120 9.7 PULSED FIELD ABLATION 121 9.7.1 IMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH 121 9.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION 122 9.8.1 INCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA TO AID MARKET GROWTH 122 9.9 OTHER ABLATION TECHNOLOGIES 123 10 ABLATION TECHNOLOGY MARKET, BY PRODUCT 125 10.1 INTRODUCTION 126 10.2 SYSTEMS 126 10.2.1 RADIOFREQUENCY ABLATION SYSTEMS 127 10.2.1.1 Temperature-controlled RF ablation systems 128 10.2.1.1.1 Technological advancements and improved clinical outcomes to propel segment growth 128 10.2.1.2 Irrigated RF ablation systems 129 10.2.1.2.1 Enhanced lesion formation and improved procedural efficiency to support market growth 129 10.2.1.3 Multi-electrode RF ablation systems 130 10.2.1.3.1 Reduced procedure time and improved ablation precision to accelerate segment adoption 130 10.2.1.4 Bipolar RF systems 131 10.2.1.4.1 Superior energy delivery control and precise tissue targeting to drive market growth 131 10.2.2 LASER/LIGHT ABLATION SYSTEMS 132 10.2.2.1 Excimer laser ablation systems 133 10.2.2.1.1 Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoption 133 10.2.2.2 CO2 laser ablation systems 134 10.2.2.2.1 High precision tissue vaporization and minimal bleeding to support market growth 134 10.2.2.3 Diode laser ablation systems 135 10.2.2.3.1 Compact design, energy efficiency, and versatile clinical applications to accelerate segment growth 135 10.2.2.4 Other laser/light ablation systems 136 10.2.3 ULTRASOUND ABLATION SYSTEMS 137 10.2.3.1 High-intensity focused ultrasound ablation systems 138 10.2.3.1.1 Low procedural time and reduced bleeding to support system adoption 138 10.2.3.2 Magnetic resonance-guided focused ultrasound ablation systems 139 10.2.3.2.1 Non-pregnancy safe treatment procedure to limit adoption 139 10.2.4 CRYOABLATION SYSTEMS 140 10.2.4.1 Technological advancements and introduction of new cryoprobes to aid adoption 140 10.2.5 PULSED FIELD ABLATION SYSTEMS 141 10.2.5.1 Tissue-selective ablation and reduced thermal injury to accelerate market adoption 141   10.2.6 MICROWAVE ABLATION SYSTEMS 143 10.2.6.1 Production of large ablation zones without a heat-sink effect on surrounding tissues to drive market 143 10.2.7 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS 144 10.2.7.1 Increased need for minimally invasive procedures for gynecological disorders to support market growth 144 10.2.8 OTHER ABLATION SYSTEMS 145 10.3 CONSUMABLES 147 10.3.1 GROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH 147 11 ABLATION TECHNOLOGY MARKET, BY APPLICATION 148 11.1 INTRODUCTION 149 11.2 CVD TREATMENT 149 11.2.1 INCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH 149 11.3 CANCER TREATMENT 150 11.3.1 HIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTH 150 11.3.2 LIVER CANCER 151 11.3.3 KIDNEY CANCER 151 11.3.4 PROSTATE CANCER 151 11.3.5 LUNG CANCER 151 11.3.6 BONE METASTASIS 152 11.3.7 BREAST CANCER 152 11.4 ORTHOPEDIC TREATMENT 153 11.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH 153 11.5 COSMETIC/AESTHETIC SURGERY 154 11.5.1 INCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH 154 11.6 UROLOGICAL TREATMENT 155 11.6.1 HIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET 155 11.7 GYNECOLOGICAL TREATMENT 155 11.7.1 INCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH 155 11.8 PAIN MANAGEMENT 156 11.8.1 MINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH 156 11.9 OPHTHALMOLOGICAL TREATMENT 157 11.9.1 RISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH 157 11.10 OTHER APPLICATIONS 158   12 ABLATION TECHNOLOGY MARKET, BY END USER 159 12.1 INTRODUCTION 160 12.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS 160 12.2.1 HIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 160 12.3 AMBULATORY SURGERY CENTERS 161 12.3.1 NEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS TO SPUR MARKET GROWTH 161 12.4 MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS 162 12.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH 162 12.5 OTHER END USERS 163 13 ABLATION TECHNOLOGY MARKET, BY REGION 164 13.1 INTRODUCTION 165 13.2 NORTH AMERICA 165 13.2.1 US 171 13.2.1.1 US to dominate North American market during forecast period 171 13.2.2 CANADA 175 13.2.2.1 Rising burden of cancer and growing demand for minimally invasive procedures to support market growth 175 13.3 EUROPE 180 13.3.1 GERMANY 185 13.3.1.1 Developed healthcare infrastructure and high incidence of chronic diseases to support market growth 185 13.3.2 FRANCE 189 13.3.2.1 Growing geriatric population and rising prevalence of cancer to aid market growth 189 13.3.3 UK 194 13.3.3.1 Rising target patient population and growing awareness about advanced treatment options to drive market 194 13.3.4 ITALY 198 13.3.4.1 Increasing number of clinical trials and growing focus on advanced research activities to augment market growth 198 13.3.5 SPAIN 203 13.3.5.1 Increasing government research funding and growing focus on effective cancer diagnosis to propel market growth 203 13.3.6 REST OF EUROPE 207 13.4 ASIA PACIFIC 211 13.4.1 JAPAN 217 13.4.1.1 Presence of a universal healthcare reimbursement system to augment market growth 217 13.4.2 CHINA 221 13.4.2.1 Increased patient pool and favorable government initiatives to fuel market growth 221 13.4.3 INDIA 226 13.4.3.1 Modernization of healthcare infrastructure and increased medical tourism to aid market growth 226 13.4.4 AUSTRALIA 230 13.4.4.1 Increased research investments and favorable government initiatives to spur market growth 230 13.4.5 SOUTH KOREA 235 13.4.5.1 Focus on healthcare R&D and supportive government initiatives to positively impact market growth 235 13.4.6 REST OF ASIA PACIFIC 239 13.5 LATIN AMERICA 243 13.5.1 BRAZIL 247 13.5.1.1 Increasing government funding and growing burden of chronic diseases to propel market growth 247 13.5.2 MEXICO 252 13.5.2.1 Availability of advanced care initiatives and awareness programs to fuel market growth 252 13.5.3 REST OF LATIN AMERICA 256 13.6 MIDDLE EAST & AFRICA 260 13.6.1 GCC COUNTRIES 265 13.6.1.1 Increasing healthcare modernization and rising investments in advanced medical technologies to drive market growth 265 13.6.2 REST OF MIDDLE EAST AND AFRICA 270 14 COMPETITIVE LANDSCAPE 275 14.1 INTRODUCTION 275 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 275 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET 275 14.3 REVENUE ANALYSIS, 2021–2025 277 14.4 MARKET SHARE ANALYSIS, 2025 278 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 280 14.5.1 STARS 280 14.5.2 EMERGING LEADERS 280 14.5.3 PERVASIVE PLAYERS 280 14.5.4 PARTICIPANTS 280 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 282 14.5.5.1 Company footprint 282 14.5.5.2 Region footprint 283 14.5.5.3 Type footprint 284 14.5.5.4 Product footprint 285 14.5.5.5 Application footprint 286 14.5.5.6 End-user footprint 287   14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 288 14.6.1 PROGRESSIVE COMPANIES 288 14.6.2 DYNAMIC COMPANIES 288 14.6.3 STARTING BLOCKS 288 14.6.4 RESPONSIVE COMPANIES 288 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 289 14.7 COMPANY VALUATION AND FINANCIAL METRICS 290 14.7.1 FINANCIAL METRICS 290 14.7.2 COMPANY VALUATION 291 14.7.3 BRAND COMPARISON 292 14.8 COMPETITIVE SCENARIO 293 14.8.1 PRODUCT APPROVALS 293 14.8.2 DEALS 294 14.8.3 OTHER DEVELOPMENTS 294 15 COMPANY PROFILES 295 15.1 KEY PLAYERS 295 15.1.1 JOHNSON & JOHNSON 295 15.1.1.1 Business overview 295 15.1.1.2 Products offered 296 15.1.1.3 Recent developments 297 15.1.1.3.1 Product approvals 297 15.1.1.3.2 Deals 298 15.1.1.3.3 Other developments 298 15.1.1.4 MnM view 298 15.1.1.4.1 Key strengths 298 15.1.1.4.2 Strategic choices 299 15.1.1.4.3 Weaknesses and competitive threats 299 15.1.2 MEDTRONIC 300 15.1.2.1 Business overview 300 15.1.2.2 Products offered 301 15.1.2.3 Recent developments 304 15.1.2.3.1 Product approvals 304 15.1.2.3.2 Deals 305 15.1.2.4 MnM view 305 15.1.2.4.1 Key strengths 305 15.1.2.4.2 Strategic choices 306 15.1.2.4.3 Weaknesses and competitive threats 306 15.1.3 BOSTON SCIENTIFIC CORPORATION 307 15.1.3.1 Business overview 307 15.1.3.2 Products offered 308 15.1.3.3 Recent developments 310 15.1.3.3.1 Product approvals 310 15.1.3.3.2 Deals 311 15.1.3.4 MnM view 312 15.1.3.4.1 Key strengths 312 15.1.3.4.2 Strategic choices made 312 15.1.3.4.3 Weaknesses and competitive threats 312 15.1.4 ABBOTT LABORATORIES 313 15.1.4.1 Business overview 313 15.1.4.2 Products offered 314 15.1.4.3 Recent developments 315 15.1.4.3.1 Product approvals 315 15.1.4.3.2 Deals 315 15.1.4.4 MnM view 316 15.1.4.4.1 Key strengths 316 15.1.4.4.2 Strategic choices made 316 15.1.4.4.3 Weaknesses and competitive threats 316 15.1.5 ATRICURE, INC. 317 15.1.5.1 Business overview 317 15.1.5.2 Products offered 318 15.1.5.3 Recent developments 319 15.1.5.3.1 Product launches and approvals 319 15.1.5.4 MnM view 320 15.1.5.4.1 Key strengths 320 15.1.5.4.2 Strategic choices made 320 15.1.5.4.3 Weaknesses and competitive threats 320 15.1.6 ANGIODYNAMICS 321 15.1.6.1 Business overview 321 15.1.6.2 Products offered 322 15.1.6.3 Recent developments 323 15.1.6.3.1 Product approvals 323 15.1.6.3.2 Deals 323 15.1.7 CONMED CORPORATION 324 15.1.7.1 Business overview 324 15.1.7.2 Products offered 325 15.1.8 OLYMPUS CORPORATION 326 15.1.8.1 Products offered 327 15.1.8.2 Recent developments 328 15.1.8.2.1 Product launches 328 15.1.8.2.2 Deals 328 15.1.9 VARIAN MEDICAL SYSTEMS, INC. 329 15.1.9.1 Business overview 329 15.1.9.2 Products offered 330 15.1.9.3 Recent developments 331 15.1.9.3.1 Product launches & approvals 331 15.1.9.3.2 Deals 331 15.1.10 SMITH+NEPHEW 333 15.1.10.1 Business overview 333 15.1.10.2 Product offered 334 15.1.10.3 Recent developments 335 15.1.10.3.1 Expansions 335 15.1.11 STRYKER 336 15.1.11.1 Business overview 336 15.1.11.2 Products offered 337 15.1.11.3 Recent developments 337 15.1.11.3.1 Product approvals 337 15.1.11.3.2 Expansions 338 15.1.12 MICROPORT SCIENTIFIC CORPORATION 339 15.1.12.1 Business overview 339 15.1.12.2 Products offered 340 15.1.12.3 Recent developments 341 15.1.12.3.1 Product approvals 341 15.1.13 CYNOSURE LUTRONIC 342 15.1.13.1 Business overview 342 15.1.13.2 Products offered 342 15.1.13.3 Recent developments 343 15.1.13.3.1 Deals 343 15.1.14 BIOTRONIK SE & CO. KG 344 15.1.14.1 Business overview 344 15.1.14.2 Products offered 344 15.1.14.3 Recent developments 345 15.1.14.3.1 Deals 345 15.1.15 MERIT MEDICAL SYSTEMS 346 15.1.15.1 Business overview 346 15.1.15.2 Products offered 347 15.1.15.3 Recent developments 348 15.1.15.3.1 Deals 348 15.1.16 ARTHREX, INC. 349 15.1.16.1 Business overview 349 15.1.16.2 Products offered 349 15.2 OTHER PLAYERS 350 15.2.1 HOLOGIC, INC. 350 15.2.2 ICECURE MEDICAL 351 15.2.3 MINIMAX MEDICAL HOLDING GROUP 352 15.2.4 CARDIOFOCUS 353 15.2.5 EMBLATION LTD. 354 15.2.6 MERMAID MEDICAL 355 15.2.7 MONTERIS 355 15.2.8 SONABLATE CORP. 356 15.2.9 ECO MEDICAL 357 15.2.10 SURGNOVA 358 16 RESEARCH METHODOLOGY 359 16.1 RESEARCH DATA 359 16.1.1 SECONDARY DATA 360 16.1.1.1 Key secondary sources 360 16.1.1.2 Objectives of secondary research 360 16.1.1.3 Key data from secondary sources 361 16.1.2 PRIMARY DATA 361 16.1.2.1 Key data from primary sources 362 16.1.2.2 Key industry insights 363 16.2 MARKET SIZE ESTIMATION 363 16.2.1 BOTTOM-UP APPROACH 363 16.2.2 TOP-DOWN APPROACH 364 16.2.3 BASE NUMBER ESTIMATION 364 16.3 MARKET FORECAST APPROACH 366 16.4 MARKET BREAKDOWN AND DATA TRIANGULATION 368 16.5 ASSUMPTIONS 369 16.6 GROWTH RATE ASSUMPTIONS 369 16.7 FACTOR ANALYSIS 370 16.8 RISK ASSESSMENT 370 16.9 METHODOLOGY-RELATED LIMITATIONS 371 17 APPENDIX 372 17.1 DISCUSSION GUIDE 372 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 377 17.3 CUSTOMIZATION OPTIONS 379 17.4 RELATED REPORTS 379 17.5 AUTHOR DETAILS 380

TABLE 1 ABLATION TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS 35 TABLE 2 ESTIMATED GERIATRIC POPULATION, BY REGION, 2023 VS. 2050 (IN MILLION) 51 TABLE 3 ALTERNATIVE THERAPIES/PROCEDURES FOR ABLATION 53 TABLE 4 ABLATION TECHNOLOGY MARKET: CURRENT UNMET NEEDS 58 TABLE 5 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 64 TABLE 6 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030 66 TABLE 7 AVERAGE SELLING PRICE TREND OF ABLATION TECHNOLOGIES FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2025 (USD MILLION) 72 TABLE 8 AVERAGE PRICING TREND OF ABLATION TECHNOLOGIES, BY REGION, 2023–2025 (USD MILLION) 72 TABLE 9 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY, 2021–2025 (USD THOUSAND) 73 TABLE 10 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY, 2021–2025 (USD THOUSAND) 74 TABLE 11 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026–2027) 74 TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 79 TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ABLATION TECHNOLOGY 79 TABLE 14 THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING 83 TABLE 15 NON-THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING 84 TABLE 16 ABLATION TECHNOLOGY MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 93 TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94 TABLE 18 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 19 US FDA: MEDICAL DEVICE CLASSIFICATION 98 TABLE 20 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 98 TABLE 21 US: CLASSIFICATION OF ABLATION DEVICES 99 TABLE 22 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 100 TABLE 23 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 104 TABLE 24 CHINA: CLASSIFICATION OF MEDICAL DEVICES 105 TABLE 25 GLOBAL STANDARDS IN ABLATION TECHNOLOGY MARKET 107 TABLE 26 CERTIFICATIONS, LABELING, ECO-STANDARDS IN ABLATION TECHNOLOGY MARKET 108 TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 110 TABLE 28 KEY BUYING CRITERIA FOR END USERS 111 TABLE 29 ABLATION TECHNOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS 112 TABLE 30 ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 115 TABLE 31 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 116 TABLE 32 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 117 TABLE 33 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 118 TABLE 34 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 120 TABLE 35 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 121 TABLE 36 PULSED FIELD ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 122 TABLE 37 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 38 OTHER ABLATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 124 TABLE 39 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 126 TABLE 40 ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 126 TABLE 41 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 42 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 127 TABLE 43 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 128 TABLE 44 TEMPERATURE-CONTROLLED RF ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 129 TABLE 45 IRRIGATED RF ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 46 MULTI-ELECTRODE RF ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 47 BIPOLAR RF ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 132 TABLE 48 LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 49 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 50 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 133 TABLE 51 EXCIMER LASER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 52 CO2 LASER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 53 DIODE LASER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 54 OTHER LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 137 TABLE 55 ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137 TABLE 56 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 57 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 138 TABLE 58 HIFU ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 59 MRGFUS ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 60 CRYOABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 141 TABLE 61 CRYOABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 141 TABLE 62 PULSED FIELD ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 63 PULSED FIELD ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 142 TABLE 64 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 65 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 144 TABLE 66 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 67 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 145 TABLE 68 OTHER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 69 OTHER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 146 TABLE 70 ABLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 71 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 149 TABLE 72 ABLATION TECHNOLOGY MARKET FOR CVD TREATMENT, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 73 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 74 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 75 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 76 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 77 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 78 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 79 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 80 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 81 ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 160 TABLE 82 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2024–2031 (USD MILLION) 161 TABLE 83 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 84 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 85 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 86 ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 87 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 88 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 167 TABLE 89 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 167 TABLE 90 NORTH AMERICA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168 TABLE 91 NORTH AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 168 TABLE 92 NORTH AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 93 NORTH AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 94 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 170 TABLE 95 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 170 TABLE 96 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 97 US: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 172 TABLE 98 US: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 172 TABLE 99 US: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 100 US: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 101 US: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 174 TABLE 102 US: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 174 TABLE 103 US: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 175 TABLE 104 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 176 TABLE 105 CANADA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 176 TABLE 106 CANADA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 107 CANADA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 108 CANADA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 109 CANADA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 110 CANADA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 179 TABLE 111 CANADA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 179 TABLE 112 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 113 EUROPE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 181 TABLE 114 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 181 TABLE 115 EUROPE: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 116 EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 117 EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 183 TABLE 118 EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 183 TABLE 119 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 184 TABLE 120 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 184 TABLE 121 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 122 GERMANY: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 186 TABLE 123 GERMANY: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 124 GERMANY: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 125 GERMANY: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 126 GERMANY: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 127 GERMANY: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 188 TABLE 128 GERMANY: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 189 TABLE 129 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 190 TABLE 130 FRANCE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 190 TABLE 131 FRANCE: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 132 FRANCE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 133 FRANCE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 134 FRANCE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 135 FRANCE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193 TABLE 136 FRANCE: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 193 TABLE 137 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 138 UK: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195 TABLE 139 UK: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 140 UK: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 141 UK: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 142 UK: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 143 UK: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197 TABLE 144 UK: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 198 TABLE 145 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 146 ITALY: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 199 TABLE 147 ITALY: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 148 ITALY: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 149 ITALY: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 150 ITALY: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 151 ITALY: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 202 TABLE 152 ITALY: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 202 TABLE 153 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 154 SPAIN: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 203 TABLE 155 SPAIN: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 156 SPAIN: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 157 SPAIN: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 158 SPAIN: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 159 SPAIN: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 206 TABLE 160 SPAIN: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 206 TABLE 161 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 162 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 208 TABLE 163 REST OF EUROPE: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 164 REST OF EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 165 REST OF EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 166 REST OF EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 167 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 210 TABLE 168 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 211 TABLE 169 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 170 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 171 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 213 TABLE 172 ASIA PACIFIC: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 173 ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 174 ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 175 ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 176 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 216 TABLE 177 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 178 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 179 JAPAN: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 218 TABLE 180 JAPAN: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 181 JAPAN: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 182 JAPAN: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 183 JAPAN: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 184 JAPAN: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 220 TABLE 185 JAPAN: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 221 TABLE 186 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 187 CHINA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 222 TABLE 188 CHINA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 189 CHINA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 190 CHINA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 191 CHINA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 192 CHINA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 225 TABLE 193 CHINA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 225 TABLE 194 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 195 INDIA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 227 TABLE 196 INDIA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 197 INDIA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 198 INDIA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 199 INDIA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 200 INDIA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 229 TABLE 201 INDIA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 230 TABLE 202 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 203 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 231 TABLE 204 AUSTRALIA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 205 AUSTRALIA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 206 AUSTRALIA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 207 AUSTRALIA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 208 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 234 TABLE 209 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 234 TABLE 210 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 211 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 235 TABLE 212 SOUTH KOREA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 213 SOUTH KOREA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 214 SOUTH KOREA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 215 SOUTH KOREA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 216 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 238 TABLE 217 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 238 TABLE 218 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 219 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 239 TABLE 220 REST OF ASIA PACIFIC: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 221 REST OF ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 222 REST OF ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 223 REST OF ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 224 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 242 TABLE 225 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 242 TABLE 226 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 227 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 228 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 244 TABLE 229 LATIN AMERICA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 230 LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 231 LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 232 LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 233 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 246 TABLE 234 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 247 TABLE 235 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 236 BRAZIL: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 248 TABLE 237 BRAZIL: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 238 BRAZIL: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 239 BRAZIL: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 240 BRAZIL: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 241 BRAZIL: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 251 TABLE 242 BRAZIL: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 251 TABLE 243 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 244 MEXICO: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 253 TABLE 245 MEXICO: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 246 MEXICO: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 247 MEXICO: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 248 MEXICO: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 249 MEXICO: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 255 TABLE 250 MEXICO: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 256 TABLE 251 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 252 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 257 TABLE 253 REST OF LATIN AMERICA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 254 REST OF LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 255 REST OF LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 256 REST OF LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 257 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 259 TABLE 258 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 260 TABLE 259 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 261 TABLE 260 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 261 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 262 TABLE 262 MIDDLE EAST & AFRICA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 263 MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 264 MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 265 MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 266 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 264 TABLE 267 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 265 TABLE 268 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 269 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 266 TABLE 270 GCC COUNTRIES: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 271 GCC COUNTRIES: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 272 GCC COUNTRIES: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 273 GCC COUNTRIES: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 274 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 269 TABLE 275 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 269 TABLE 276 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 277 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 271 TABLE 278 REST OF MIDDLE EAST & AFRICA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 279 REST OF MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 280 REST OF MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 281 REST OF MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 282 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 273 TABLE 283 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 274 TABLE 284 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET 275 TABLE 285 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION 278 TABLE 286 ABLATION TECHNOLOGY MARKET: REGION FOOTPRINT 283 TABLE 287 ABLATION TECHNOLOGY MARKET: TECHNOLOGY FOOTPRINT 284 TABLE 288 ABLATION TECHNOLOGY MARKET: PRODUCT FOOTPRINT 285 TABLE 289 ABLATION TECHNOLOGY MARKET: APPLICATION FOOTPRINT 286 TABLE 290 ABLATION TECHNOLOGY MARKET: END-USER FOOTPRINT 287 TABLE 291 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 289 TABLE 292 ABLATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 290 TABLE 293 ABLATION TECHNOLOGY MARKET: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 293 TABLE 294 ABLATION TECHNOLOGY MARKET: DEALS, JANUARY 2021–MAY 2026 294 TABLE 295 ABLATION TECHNOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2026 294 TABLE 296 JOHNSON & JOHNSON: COMPANY OVERVIEW 295 TABLE 297 JOHNSON & JOHNSON: PRODUCTS OFFERED 296 TABLE 298 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 297 TABLE 299 JOHNSON & JOHNSON: DEALS, JANUARY 2021–MAY 2026 298 TABLE 300 JOHNSON & JOHNSON: OTHER DEVELOPMENTS, JANUARY 2021−MAY 2026 298 TABLE 301 MEDTRONIC: COMPANY OVERVIEW 300 TABLE 302 MEDTRONIC: PRODUCTS OFFERED 301 TABLE 303 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 304 TABLE 304 MEDTRONIC: DEALS, JANUARY 2021–MAY 2026 305 TABLE 305 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 307 TABLE 306 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 308 TABLE 307 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021−MAY 2026 310 TABLE 308 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–MAY 2026 311 TABLE 309 ABBOTT LABORATORIES: COMPANY OVERVIEW 313 TABLE 310 ABBOTT LABORATORIES: PRODUCTS OFFERED 314 TABLE 311 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 315 TABLE 312 ABBOTT LABORATORIES: DEALS, JANUARY 2021–MAY 2026 315 TABLE 313 ATRICURE, INC.: COMPANY OVERVIEW 317 TABLE 314 ATRICURE, INC.: PRODUCTS OFFERED 318 TABLE 315 ATRICURE, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−MAY 2026 319 TABLE 316 ANGIODYNAMICS: COMPANY OVERVIEW 321 TABLE 317 ANGIODYNAMICS: PRODUCTS OFFERED 322 TABLE 318 ANGIODYNAMICS: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 323 TABLE 319 ANGIODYNAMICS: DEALS, JANUARY 2021–MAY 2026 323 TABLE 320 CONMED CORPORATION: COMPANY OVERVIEW 324 TABLE 321 CONMED CORPORATION: PRODUCTS OFFERED 325 TABLE 322 OLYMPUS CORPORATION: COMPANY OVERVIEW 326 TABLE 323 OLYMPUS CORPORATION: PRODUCTS OFFERED 327 TABLE 324 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021- FEBRUARY 2025 328 TABLE 325 OLYMPUS CORPORATION: DEALS, JANUARY 2021- FEBRUARY 2025 328 TABLE 326 VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 329 TABLE 327 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 330 TABLE 328 VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−MAY 2026 331 TABLE 329 VARIAN MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–MAY 2026 331 TABLE 330 SMITH+NEPHEW: COMPANY OVERVIEW 333 TABLE 331 SMITH+NEPHEW: PRODUCTS OFFERED 334 TABLE 332 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–MAY 2026 335 TABLE 333 STRYKER: COMPANY OVERVIEW 336 TABLE 334 STRYKER: PRODUCTS OFFERED 337 TABLE 335 STRYKER: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 337 TABLE 336 STRYKER: EXPANSIONS, JANUARY 2021- FEBRUARY 2025 338 TABLE 337 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 339 TABLE 338 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 340 TABLE 339 MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 341 TABLE 340 CYNOSURE LUTRONIC: COMPANY OVERVIEW 342 TABLE 341 CYNOSURE LUTRONIC: PRODUCTS OFFERED 342 TABLE 342 CYNOSURE LUTRONIC: DEALS, JANUARY 2021- FEBRUARY 2025 343 TABLE 343 BIOTRONIK SE & CO. KG: COMPANY OVERVIEW 344 TABLE 344 BIOTRONIK SE & CO. KG: PRODUCTS OFFERED 344 TABLE 345 BIOTRONIK SE & CO. KG: DEALS, JANUARY 2021–MAY 2026 345 TABLE 346 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 346 TABLE 347 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 347 TABLE 348 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021−MAY 2026 348 TABLE 349 ARTHREX, INC.: COMPANY OVERVIEW 349 TABLE 350 ARTHREX, INC.: PRODUCTS OFFERED 349 TABLE 351 HOLOGIC, INC.: COMPANY OVERVIEW 350 TABLE 352 ICECURE MEDICAL: COMPANY OVERVIEW 351 TABLE 353 MINIMAX MEDICAL HOLDING GROUP: COMPANY OVERVIEW 352 TABLE 354 CARDIOFOCUS: COMPANY OVERVIEW 353 TABLE 355 EMBLATION LTD.: COMPANY OVERVIEW 354 TABLE 356 MERMAID MEDICAL: COMPANY OVERVIEW 355 TABLE 357 MONTERIS: COMPANY OVERVIEW 355 TABLE 358 SONABLATE CORP.: COMPANY OVERVIEW 356 TABLE 359 ECO MEDICAL: COMPANY OVERVIEW 357 TABLE 360 SURGNOVA: COMPANY OVERVIEW 358 TABLE 361 ABLATION TECHNOLOGY MARKET: STUDY ASSUMPTIONS 369 TABLE 362 ABLATION TECHNOLOGY MARKET: RISK ASSESSMENT 370 FIGURE 1 ABLATION TECHNOLOGY MARKET: YEARS CONSIDERED 35 FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 38 FIGURE 3 ABLATION TECHNOLOGY MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 39 FIGURE 4 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2026 VS. 2031 (USD MILLION) 39 FIGURE 5 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION) 40 FIGURE 6 ABLATION TECHNOLOGY MARKET, BY END USER, 2026 VS. 2031 (USD MILLION) 41 FIGURE 7 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET 41 FIGURE 8 DISRUPTIVE TRENDS IMPACTING GROWTH OF ABLATION TECHNOLOGY MARKET 42 FIGURE 9 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN ABLATION TECHNOLOGY MARKET, 2026 43 FIGURE 10 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 44 FIGURE 11 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET 45 FIGURE 12 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF ABLATION TECHNOLOGY MARKET IN 2025 46 FIGURE 13 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47 FIGURE 14 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 48 FIGURE 15 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 48 FIGURE 16 ABLATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49 FIGURE 17 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 64 FIGURE 18 ABLATION TECHNOLOGY MARKET SUPPLY CHAIN ANALYSIS 69 FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 70 FIGURE 20 ABLATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 71 FIGURE 21 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES IN ABLATION 75 FIGURE 22 INVESTMENT/VENTURE CAPITAL SCENARIO IN ABLATION TECHNOLOGY MARKET, 2020–2023 76 FIGURE 23 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ABLATION TECHNOLOGY MARKET (JANUARY 2016–APRIL 2026) 88 FIGURE 24 TOP PATENT APPLICANT COUNTRIES FOR ABLATION TECHNOLOGY (JANUARY 2016–APRIL 2026) 89 FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 99 FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 100 FIGURE 27 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 102 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ABLATION TECHNOLOGY PRODUCTS 109 FIGURE 29 KEY BUYING CRITERIA FOR END USERS 110 FIGURE 30 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT 166 FIGURE 31 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT 212 FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN ABLATION TECHNOLOGY MARKET (2021−2025) 277 FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ABLATION TECHNOLOGY MARKET (2025) 278 FIGURE 34 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 281 FIGURE 35 ABLATION TECHNOLOGY MARKET: COMPANY FOOTPRINT 282 FIGURE 36 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 289 FIGURE 37 EV/EBITDA OF KEY VENDORS 290 FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR 291 FIGURE 39 ABLATION TECHNOLOGY MARKET: BRAND COMPARATIVE ANALYSIS 292 FIGURE 40 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025) 296 FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT (2025) 301 FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 308 FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2025) 314 FIGURE 44 ATRICURE, INC.: COMPANY SNAPSHOT (2025) 318 FIGURE 45 ANGIODYNAMICS: COMPANY SNAPSHOT (2025) 322 FIGURE 46 CONMED CORPORATION: COMPANY SNAPSHOT (2025) 325 FIGURE 47 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2025) 327 FIGURE 48 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2025) 330 FIGURE 49 SMITH+NEPHEW: COMPANY SNAPSHOT (2025) 334 FIGURE 50 STRYKER: COMPANY SNAPSHOT (2024) 336 FIGURE 51 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 340 FIGURE 52 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022) 347 FIGURE 53 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN 359 FIGURE 54 PRIMARY SOURCES 362 FIGURE 55 BOTTOM-UP APPROACH 364 FIGURE 56 TOP-DOWN APPROACH 364 FIGURE 57 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 365 FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: JOHNSON &JOHNSON 365 FIGURE 59 SUPPLY-SIDE MARKET ESTIMATION: ABLATION TECHNOLOGY MARKET (2025) 366 FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 367 FIGURE 61 DATA TRIANGULATION METHODOLOGY 368